sustained throughout life in a highly ordered manner 1,2 . Homeostasis within the stem-cell compartment is governed by positive-and negative-feedback regulation of instructive extrinsic and intrinsic signals 3,4 . ErbB signalling is a prerequisite for maintenance of the intestinal epithelium following injury and tumour formation 5,6 . As ErbB-family ligands and receptors are highly expressed within the stem-cell niche 7 , we hypothesize that strong endogenous regulators must control the pathway in the stem-cell compartment. Here we show that Lrig1, a negative-feedback regulator of the ErbB receptor family 8-10 , is highly expressed by intestinal stem cells and controls the size of the intestinal stem-cell niche by regulating the amplitude of growth-factor signalling. Intestinal stem-cell maintenance has so far been attributed to a combination of Wnt and Notch activation and Bmpr inhibition 11-13 . Our findings reveal ErbB activation as a strong inductive signal for stem-cell proliferation. This has implications for our understanding of ErbB signalling in tissue development and maintenance and the progression of malignant disease.
cell turnover of the differentiated compartment 16, 17 . Lgr5 (leucine rich repeat containing G protein coupled receptor 5)-expressing crypt-based columnar cells at the bottom of crypts are together with cells located immediately above this region responsible for the life-long steady-state maintenance of the epithelium 14, 15, 18, 19 . How ISCs are maintained and which inductive signals are required for tissue maintenance is well established; however, very little is known with regard to the regulation of these pathways in vivo.
We recently demonstrated that Lrig1 (leucine-rich repeats and immunoglobulin-like domains 1) controls stem-cell proliferation in the epidermis 20 . In situ hybridization now reveals that Lrig1 is highly expressed in the stem-cell niche of the small intestine and colon ( Fig. 1a and Supplementary Fig. S1 ). Lgr5-expressing stem cells can be identified by their high levels of green fluorescent protein (GFP) in the Lgr5 -eGFP -IRES -CreERT2 knock-in mouse 14 . GFP is subsequently diluted during successive cell divisions of stem cells (GFP high ) and their early daughter cells (GFP mid and GFP low ). Expression analysis of these different populations demonstrates that Lrig1 levels are highest within the ISCs (GFP high versus GFP mid , 1.6-fold; GFP high versus GFP low , 2.2-fold). Immunofluorescence staining and flow cytometric analysis confirm the overlap of Lrig1 and Lgr5 expression at the protein level and that Lrig1 is expressed in a gradient with highest levels in ISCs and is absent from Paneth cells (Fig. 1b,c and Supplementary  Fig. S2a-c) . Overall, approximately one-third of all cells within the intestinal crypt express Lrig1 (Fig. 1d ). This comprises the entire Cd24 low/mid stem-cell and progenitor compartment and includes all of the Lgr5 + ISCs (ref. 21 ; Fig. 1e knock-in mouse, where a large fraction of Lgr5-expressing ISCs are GFP negative (http://jaxmice.jax.org/strain/008875.html; Supplementary  Fig. S1 ). Characterization of Lrig1 + cells isolated by flow cytometry demonstrates that markers that define ISCs, such as Lgr5, Ascl2 and Msi1, are all enriched in this population ( Fig. 1h ; refs 19,22) . We also observe differential expression of multiple transcripts for Lrig1 interaction partners, in particular epidermal growth factor receptor (Egfr) (6.2-fold, Fig. 1h ). Expression of Lrig1 is associated with reduced proliferation in other tissues 20 . Therefore, we test whether Lrig1-expressing cells are mainly quiescent or proliferative. Pulse-chase studies show that 15-20% of the Lrig1-expressing cells incorporate 5-bromodeoxyuridine (BrdU) within 1 h following one injection and 60% are labelled after a three-day pulse with seven injections (Fig. 1i ).
The BrdU label is subsequently lost or significantly reduced following a one-week chase ( Supplementary Fig. S2d-e ). We conclude that Lrig1 is highly expressed by all ISCs, that the majority of Lrig1-expressing cells are proliferating and that the expression of Egfr is enriched within the Lrig1 + population. Work with Lrig1-knockout mice has until now been carried out on an outbred genetic mouse background 20, 23 . To eliminate the contribution of genetic variability in the interpretation of the effects of Lrig1, we backcrossed Lrig1-knockout mice to an FVB/N background for more than seven generations. On this background, no differences are observed between heterozygous (Het) and wild-type littermates. Yet, Lrig1-knockout animals are smaller than their littermates from postnatal day 8 onwards and have to be killed around postnatal day 10 owing to the severity of the phenotype. Although the sizes of most organs are in relative proportion to the reduced body weight, the relative size of the intestine is grossly enlarged in Lrig1-knockout mice ( Fig. 2a-d ; circumference, 7.3 ± 0.5 mm for wild type/Het (n = 5) and 11.0±1.0 mm for knockout (n = 4); P = 0.01). Histological examination of the intestine reveals that loss of Lrig1 causes a marked increase in crypt size along the entire length of the small intestine ( Fig. 2e ,f and Supplementary Fig. S3a ). This is associated with an increased number of proliferating cells as measured by expression of phospho-histone H3 ( Fig. 2g ,h; pHistone H3 per crypt, 3.9±0.9 fold knockout/control, P = 0.05). Phenotypically, crypts from knockout mice and littermate controls are indistinguishable until postnatal day 6 ( Supplementary Fig. S3b ). This coincides with stem-cell specification in the neonatal intestinal epithelium 24 . Crypt hyperplasia can be observed from this time onwards in Lrig1-knockout animals. Gene expression profiling reflects the phenotypic change associated with loss of Lrig1 as gene set enrichment analysis shows overrepresentation of crypt signature genes within the upregulated genes (P = 1.5 × 10 −177 ; ref. 25) .
The enlarged crypt morphology can be explained by a specific increase in the transit-amplifying compartment, by a disproportionate increase in individual crypt-cell lineages or by increased numbers of ISCs with a proportionate increase in transit-amplifying and Paneth cells. The major intestinal cell lineages can be identified by their differential expression of Cd24 and binding of Ulex europaeus agluttinin 1 (UEA-1) by secretory cells ( Supplementary Fig. S4 ). Loss of Lrig1 causes a profound increase in the proportion of the Cd24 low/mid /UEA-1 − stem-cell and progenitor compartment (D) and Cd24 high /UEA-1 + Paneth cells (B), whereas the population comprising mature enterocytes is proportionally decreased (C) ( Fig. 3a,b ). Goblet (A) and enteroendocrine (E) cell populations show no significant change. In addition to their increased numbers, we observe increased expression of ISC markers within the Cd24 low/mid /UEA-1 − population, supporting an expansion of the stem-cell compartment following loss of Lrig1 ( Fig. 3c ). To confirm this finding, we carry out in situ hybridization for Olfm4 (olfactomedin 4), a marker of ISCs (ref. 22) , and Cryptdin6 (also known as Defa6 ), a marker of Paneth cells 26 . Starting from postnatal day 6 we observe an increased number of Olfm4-positive cells in Lrig1-knockout samples and from postnatal day 10 an increased proportion of Cryptdin6 -positive Paneth cells (Fig. 3d ). The dynamic expansion of the stem-cell compartment is supported by flow cytometric analysis of dissociated cells from the intestinal epithelium ( Supplementary Fig. S5a-e ). The expression domain of the independent stem-cell marker Msi1 is also expanded following loss of Lrig1 ( Supplementary Fig. S5f ,g). Taken together, this supports a direct effect of Lrig1 on ISCs, which subsequently affects the size of the ISC compartment and the crypt.
Lrig1 interacts with the ErbB family, cRet and cMet in vitro and reduces signalling strength by negatively regulating both protein levels and the activity of the growth factor receptors [8] [9] [10] 27, 28 . Epithelial cells in the intestine express detectable levels of Egfr, ErbB2, ErbB3 and cMet (Figs 1h and 4a). ErbB signalling is mediated through ligand stimulation of Egfr and ErbB3, which on homo-and heterodimerization with each other or with the orphan receptor ErbB2 activates downstream signalling cascades 29 . cMet on the other hand is activated following hepatocyte growth factor stimulation. Loss of Lrig1 causes a pronounced increase in the protein levels of all of these interaction partners irrespective of transcript levels (Fig. 4a,b ). This is associated with a concomitant increase in the activity of the ErbB family, but with no detectable effect on the activation of cMet ( Fig. 4a and data not shown). The increased ErbB activation is reflected by strong upregulation of mitogen-activated protein kinase (MAPK) signalling and increased levels and activity of the mitogen-induced transcription factor cMyc ( Fig. 4c Ncl, P = 0.002). (k) Lrig1-knockout organoids mature in the absence of exogenous ErbB ligands. Maximum-intensity projection of confocal microscopy images of wild-type and knockout organoids shows incorporation of BrdU (green) and β-catenin as counterstain (magenta). (l) Epidermal growth factor (EGF) signalling is required for organoid maturation. The branching coefficient was determined for varying concentrations of EGF for independently derived samples (n = 3 for all, except: n = 9 for control 50 ng ml −1 and n = 6 for knockout 50 ng ml −1 , control 'No EGF' and knockout 'No EGF'). The error bars represent the s.e.m. and the asterisk significant change (P = 0.009). (m) Loss of Lrig1 does not affect ErbB ligand expression. The relative levels of ErbB ligands were determined by qPCR on material from organoids grown for 6 days with (w) or without (wo) EGF. Red and green colours reflect increased and decreased deviation from the mean, respectively. The dendrogram indicates that control samples (Ctrl) grown for 6 days in normal conditions cluster with Lrig1-knockout samples (KO) grown with and without EGF. Scale bars, 50 µm (c-h) and 100 µm (k). Uncropped images of blots are shown in Supplementary Fig. S7 . 10 phosphorylation can be observed on UEA-1 + secretory cells and progenitor cells ( Supplementary Fig. S6 ). In control animals, pEgfr levels are low at the crypt bottom and peak around cell position 8 (Fig. 4g,i) . Of note, this is the reverse expression pattern of Lrig1. In Lrig1-knockout animals, Egfr activation is uniform within the crypt (Fig. 4h,i) . Second, expression analysis of isolated cell populations signifies the increased activation of Myc within ISCs and progenitors following loss of Lrig1 (Fig. 4j ). We conclude that loss of Lrig1 affects ErbB signalling within the ISC compartment.
Next, we functionally test in a defined three-dimensional intestinal culture system whether ErbB inhibition is the main function of Lrig1. ISC self-renewal and proliferation require stimulation of the Egfr and the Wnt (wingless-related MMTV integration site) pathways, and inhibition of the Bmpr (bone morphogenetic protein receptor) pathway 31 . In wild-type samples, stimulation of ErbB signalling with exogenous ligands is a prerequisite for maturation from spheres into budding organoids. Interestingly, Lrig1-knockout spheres mature into budding organoids in the absence of exogenous ErbB ligands (Fig. 4k,l) . Nevertheless, ErbB signalling, similarly to stimulation of the Wnt pathway and inhibition of Bmpr signalling, is an obligate requirement for growth of both wild-type and knockout organoids, as inhibition of ErbB signalling with a number of ErbB inhibitors rapidly affects cell survival (data not shown). Importantly, loss of Lrig1 does not cause increased expression of ErbB ligands (Fig. 4m ). We conclude that, following loss of Lrig1, endogenous ErbB ligands are sufficient to support organoid growth owing to reduced ErbB inhibition in ISCs. Moreover, as the phenotype observed in vivo can be recapitulated in vitro in a purely epithelial culture, the function of Lrig1 is likely to be crypt autonomous.
To address in vivo whether activation of the ErbB family is responsible for the observed phenotype, neonatal mice were treated daily with the ErbB inhibitor Gefitinib. Following administration of inhibitor in vivo, crypt proliferation, as well as ISC and Paneth cell numbers, is restored to normal levels in the Lrig1-knockout animals ( Fig. 5a-l) . Moreover, treatment with Gefitinib reduces pEgfr levels ( Fig. 5m-p) . Gefitinib-treated knockout animals are still significantly smaller than control animals, and we hypothesize that Lrig1 has important non-reversible functions in other tissues such as the stomach, where Lrig1 is expressed by a small sub-population of cells within the pyloric glands (M.E.P. and K.B.J., unpublished observations). The proposed mechanism of Lrig1 as an inhibitor of ErbB function in vivo is further substantiated by genetic rescue of the phenotype by crossing Lrig1-knockout animals to hypomorphic Egfr wa-2 mice (Fig. 5q-t) . The Egfr wa-2 mouse strain harbours a missense mutation in the kinase domain of Egfr, which compromises the activity of the receptor on ligand stimulation 32 . Homozygosity for Egfr wa-2 , when crossed with Lrig1-knockout mice, is associated with perinatal lethality irrespective of Lrig1 status. Analysis of the Egfr wa-2 heterozygous animals at postnatal day 10 demonstrates that the phenotypical changes associated with loss of Lrig1 are rescued in approximately 40% of the mice (n = 15 out of 37, P = 0.0095). Thus, the phenotypical changes observed on loss of Lrig1 can be rescued by both pharmacological and genetic modulation of endogenous ErbB activity, hereby demonstrating ErbB activity as the main target of Lrig1 in vivo.
Our data support a model whereby Lrig1 regulates proliferation within the ISC niche by inhibiting ErbB signalling. Expression of Lrig1 enables stem cells and progenitors to fine-tune their cellular response on ligand stimulation and ensures that tissue homeostasis is maintained (Fig. 5u ). Proliferation and maintenance of the ISC compartment have until now been attributed to Wnt and Notch activation in combination with Bmpr inhibition [11] [12] [13] . We show that ErbB signalling is a strong mitotic signal for ISCs, and when uninhibited leads to a rapid expansion of the stem-cell compartment. The prominent role of ErbB signalling in the ISC compartment is supported by recent evidence from Drosophila, where signalling through Egfr, the only ErbB receptor in Drosophila, is required for intestinal maintenance 33, 34 . Moreover, the natural response to injury and tumour initiation in the mouse intestine, which includes stem-cell activation, is severely compromised following loss of Egfr and ErbB3 (refs 5,6) . Analogous to our observations, eliminating one functional copy of Egfr significantly alters the injury response to sublethal doses of radiation 35 . In the case of injury models, it remains to be shown whether Egfr and ErbB3 function is required for expansion of the stem-cell compartment or as a general mitotic stimulus.
Owing to the reported antiproliferative effect of Lrig1 in human and murine epidermis 9,20 , we have assessed the proliferation status of Lrig1-expressing cells. As predicted from the overlap in Lrig1 and Lgr5 expression, we observe that the majority of Lrig1-expressing cells, similarly to Lgr5 + cells, are highly proliferative. We cannot rule out that mitotic heterogeneity exists within the Lrig1 + population; however, it is evident that Lrig1 does not define a population of quiescent cells in the intestine. The prominent effect on the stem-cell compartment on loss of Lrig1 does however highlight that ISCs are exposed to multiple signals that promote proliferation and that distinct inhibitory factors such as Lrig1 are required to control stem-cell behaviour.
We unambiguously demonstrate that Lrig1 is a key regulator of tissue homeostasis in the intestinal epithelium. As multiple tissue-specific stem cells rely on Lrig1 to regulate their behaviour, we propose that Lrig1 provides a general mechanism to control tissue homeostasis. On the basis of the study described here, and the non-overlapping expression pattern of Lrig1 and Lgr5 in stem cells of the epidermis 20,36 , we anticipate that distinct cellular microenvironments, which can either converge as in the intestine or diverge as in the epidermis, specify stem-cell behaviour in vivo. Egfr wa-2 and Lgr5 -eGFP-IRES-CreERT2 knock-in mice 14 have been described. Egfr Wa-2 mice crossed to FVB/N for one generation were bred with Lrig1-knockout mice. The offspring were subsequently intercrossed to obtain Lrig1-knockout mice on the hypermorphic Egfr wa-2 background. For DNA-labelling experiments mice received single or repeated intraperitoneal injections of 100 µl 10 mg ml −1 BrdU (10 mg ml −1 ) every 12 h. For experiments with Gefitinib (Cambridge Bioscience), neonatal mice received daily intraperitoneal injections of 20 µg per gram bodyweight of Gefitinib. All in vivo experiments were carried out under the terms of a UK Home Office license.
METHODS

Methods
Tissue preparation. Intestinal samples were fixed and embedded in paraffin using standard protocols. Analysis of Lgr5-GFP/Lrig1 and UEA-1/pEgfr was carried out as recently described 22 .
Antibodies. The following antibodies were used according to manufacturer's instructions: rabbit anti-β-catenin (Santa Cruz, sc-7199, 1:250), rabbit antiphospho-histone H3(Ser 10) (Cell Signaling no 9701, 1:400), rabbit anti-phospho-MEK1/2(Ser 221) (Cell Signaling, no 2338, 1:500), mouse anti-BrdU (Cell Signaling, Bu20a, 1:250), goat anti-Lrig1 (R and D Systems, AF3688, 1:100), rabbit anti-Myc (Millipore, 06-340, 1:100), mouse anti-Ki67 (Monosan, clone MM1, 1:1,000), phycoerythrin-conjugated anti-Lrig1 (R and D systems, FAB3688P, 10 µl/10 6 cells), Pacific Blue and Alexa 647-conjugated rat anti-Cd24 (BioLegend, M1/69, 5 µl/10 6 cells), rat anti-Msi1 (MBL, D270-6, 1:10,000), rabbit anti-phospho-Egfr(Tyr 1068) (Abcam, EP7774Y, 1:250), rabbit anti-Egfr (Cell Signaling, no 4267, clone D38B1, 1:250), rabbit anti-phospho-ErbB2(Tyr 1248) (Abcam, ab47755, 1:500), mouse anti-ErbB2 (Millipore, 05-1130, clone N3D10, 1:500), rabbit antiphospho-ErbB3(Tyr 1289) (Cell Signaling, no 4791, clone 21D3, 1:250), mouse anti-ErbB3 (Millipore, 05-390, clone 2F12, 1:500), rabbit anti-cMet (Santa Cruz, sc-162, 1:500), mouse anti-β-actin (Sigma, A5316, clone a.c.-74, 1:5,000) and Atto-488-conjugated UEA-1 (Sigma, 10 µl/10 6 cells for flow cytometry, 1:1,000 for near-native sections). For confocal microscopy, samples were imaged using an LSM700 confocal microscope or Leica SP5 TCS. Z-stacks were acquired at optimal stack distance and at 1024×1024 dpi resolution. Maximum-intensity projections of Z-stacks were generated in ImageJ.
RNA extraction and qPCR. One centimetre pieces of the jejunum from postnatal day 10 Lrig1-knockout and control littermates were rinsed with ice-cold PBS and snap-frozen on dry ice. RNA was isolated from homogenized intestine or flow-sorted cells and used either directly for microarray experiments or for qPCR as described 20 .
Gene-specific expression assays (Applied Biosystems) or SYBR Green analysis (Invitrogen) with optimized primer pairs were used for qPCR on an Applied Biosystems 7500HT RealTime PCR System (Applied Biosystems). Samples were normalized using the Ct method. For clustering analysis, average expression levels from at least three independent biological replicates were converted to z scores (z = (value − average value)/s.d.) and plotted using the heatmap.2 function from the Bioconductor 'gplots' library.
Microarray analysis.
RNA was quality controlled for concentration, purity and integrity using spectroStar omega (BMG labtech) and Bioanalyser (Agilent). The amplification was carried out using the TotalPrep 96-RNA amplification kit (Ambion). Total RNA (∼300 ng) was reverse transcribed into complementary DNA and amplified by in vitro transcription to generate biotin-labelled antisense RNA (cRNA). cRNA (1,500 ng) was hybridized to whole-genome bead arrays (MouseWG-6 v2.0 Expression BeadChip) according to the direct hybridization assay from Illumina and scanned using an Illumina BeadArray scanner. Bead-level data from all hybridizations were background corrected, using default parameters of the RMA algorithm 37 , and summarized using the beadarray package for the Bioconductor suite (http://www.bioconductor.org) for the R statistical programming environment (http://www.r-project.org). Processed sample expression profiles were quantile normalized using the limma package for Bioconductor before analysis of differential regulation between sample groups with the moderated t statistic of the same package 38 . To reduce errors associated with multiple hypothesis testing, the significance P values obtained were converted to corrected q values using the false discovery rate method 39 , as implemented in the qvalue package for Bioconductor. Differential regulation between two sample groups was deemed significant at a threshold of q < 0.01 (false discovery rate 1%, Supplementary Table S1 ).
To generate a reference gene universe for gene-set enrichment analysis we defined the intestinal transcriptome as genes detected in three replicates from knockout and control samples (13, 298 unique genes, 2,575 upregulated genes, 2,553 downregulated genes; Supplementary Table S2 ). For gene-set enrichment analysis using Fisher's exact test we obtained a crypt gene signature 25 (1, 692 genes in reference list, 802 genes upregulated; Supplementary Table S3 ) and a Myc-dependent gene network 30 (374 genes in reference list, 144 genes upregulated; Supplementary Table S4 ).
Western blot analysis and in situ hybridization. For protein isolation, intestinal epithelium was extracted as for organoid cultures and lysed in RIPA buffer (150 mM NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris at pH 8.0).
Digoxigenin in situ hybridization was carried out essentially as described before using IMAGE clones 40 .
Flow cytometry.
Intestinal epithelial cells were isolated as described 22 . To generate a single-cell suspension, cells were incubated with trypsin 22 or with 0.25 mg ml −1 thermolysin for 1 min at 37 • C in PBS supplemented with 1% BSA for trypsinsensitive antigens such as Lrig1. Cell sorting was carried out using a FACSAria (BD Biosciences) for isolation of cells on the basis of Cd24 and UEA-1, and a MoFlo (Dako Cytomation) for isolation of Lrig1-and Lgr5-eGFP-expressing cells. Flow cytometric analysis was carried out on a CyAn ADP analyser (Dako Cytomation), and data were processed in FlowJo.
The BrdU-labelling analysis was carried out with an APC-BrdU flow cytometry kit (BD Biosciences).
Organoid cultures. Primary crypts were cultured according to ref. 31 using reduced concentrations of murine recombinant R-spondin1 (500 ng ml −1 , R&D Systems) and varying concentrations of EGF (Peprotech). Organoid structures were imaged at day 6. Cell proliferation was measured by BrdU incorporation by incubation with 20 µM BrdU (Roche) for 1 h at 37 • C before fixation.
Image analysis.
Confocal microscopy images of intestinal samples stained for pEgfr were analysed in ImageJ to determine the levels of membrane-localized pEgfr. Intra-crypt intensities were normalized to the average intensity of positions 6-10. This corresponds to the peak in control samples.
Organoids in Matrigel were observed under phase contrast using an Axiovert 200M microscope (Zeiss) equipped with an AxioCam MRc (Zeiss). Images were interactively analysed using ImageJ to determine the perimeter and area of individual organoids and calculate the branching coefficient (1 − 4π (area/perimeter 2 )) of the formed structures. Images were acquired from a minimum of eight organoids per condition derived from independent knockout and control samples, Statistical analysis. Statistical significance of quantitative data was determined by applying a two-tailed Student t -test to raw values or to the average values obtained from analysis of independent organoid experiments. A two-tailed Fisher exact test was used to analyse the significance of the genetic rescue of the Lrig1-knockout phenotype, and to determine the significant overlap between different gene lists. 
